Literature DB >> 6139671

Cyproterone acetate in treatment of post-orchidectomy hot flushes. Double-blind cross-over trial.

A C Eaton, N McGuire.   

Abstract

12 patients with troublesome hot flushes after orchidectomy (as a primary treatment for prostatic carcinoma) were treated with cyproterone acetate or placebo in a double-blind cross-over trial. The frequency of hot flushes was significantly reduced during the three weeks that cyproterone acetate (100 mg three times a day) was given. 5 patients complained of lassitude while on cyproterone acetate, but in none was it necessary to discontinue treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139671     DOI: 10.1016/s0140-6736(83)91092-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Breathlessness in patients with prostatic carcinoma treated with cyproterone acetate.

Authors:  N A Green; B D Harrison
Journal:  BMJ       Date:  1989-06-03

2.  Hot flashes in men with testicular insufficiency.

Authors:  W A Norcross; J D Schmidt
Journal:  West J Med       Date:  1986-10

Review 3.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

4.  Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial.

Authors:  Reem J Al-Bareeq; A Andrew Ray; Linda Nott; Stephen E Pautler; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

Review 5.  Optimal delivery of male breast cancer follow-up care: improving outcomes.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.